CAPRICOR THERAPEUTICS INC (CAPR) — insider trading
Health Care · NASDAQ
CAPRICOR THERAPEUTICS INC (CAPR) has 39 reported SEC Form 4 insider transactions in our data, including 10 open-market sales among the most recent 39 (latest 2026-06-25).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-25 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion (derivative) | 24,100 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 24,100 | $30.38 | $732.2K | Form 4 |
| 2026-06-25 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion | 24,100 | $3.18 | $76.6K | Form 4 |
| 2026-06-25 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 24,100 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Open-market sale | 24,100 | $30.38 | $732.2K | Form 4 |
| 2026-06-25 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 24,100 | $3.18 | $76.6K | Form 4 |
| 2026-06-24 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion (derivative) | 400 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 400 | $30.00 | $12.0K | Form 4 |
| 2026-06-24 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion | 400 | $3.18 | $1.3K | Form 4 |
| 2026-06-24 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 400 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Open-market sale | 400 | $30.00 | $12.0K | Form 4 |
| 2026-06-24 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 400 | $3.18 | $1.3K | Form 4 |
| 2026-06-22 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion (derivative) | 500 | $0.00 | $0 | Form 4 |
| 2026-06-22 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 500 | $30.00 | $15.0K | Form 4 |
| 2026-06-22 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion | 500 | $3.18 | $1.6K | Form 4 |
| 2026-06-22 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 500 | $0.00 | $0 | Form 4 |
| 2026-06-22 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Open-market sale | 500 | $30.00 | $15.0K | Form 4 |
| 2026-06-22 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 500 | $3.18 | $1.6K | Form 4 |
| 2026-05-26 | Maurer Michael T | Officer (CHIEF COMMERCIAL OFFICER) | Grant / award / vesting (derivative) | 80,000 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion (derivative) | 3,000 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion | 3,000 | $1.39 | $4.2K | Form 4 |
| 2026-05-13 | Litvack Frank | Director | Option exercise / conversion (derivative) | 3,937 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Litvack Frank | Director | Option exercise / conversion | 3,937 | $1.39 | $5.5K | Form 4 |
| 2026-05-01 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion (derivative) | 25,000 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 25,000 | $31.70 | $792.5K | Form 4 |
| 2026-05-01 | Bergmann Anthony | Officer (CHIEF FINANCIAL OFFICER) | Option exercise / conversion | 25,000 | $3.18 | $79.5K | Form 4 |
| 2026-05-01 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 25,000 | $0.00 | $0 | Form 4 |
| 2026-05-01 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Open-market sale | 25,000 | $31.70 | $792.5K | Form 4 |
| 2026-05-01 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 25,000 | $3.18 | $79.5K | Form 4 |
| 2026-04-02 | Sabar Karimah Es | Director | Option exercise / conversion (derivative) | 7,529 | $0.00 | $0 | Form 4 |
| 2026-04-02 | Sabar Karimah Es | Director | Open-market sale | 7,529 | $32.00 | $240.9K | Form 4 |
| 2026-04-02 | Sabar Karimah Es | Director | Option exercise / conversion | 7,529 | $3.18 | $23.9K | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 2,819 | $0.00 | $0 | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 21,488 | $0.00 | $0 | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion (derivative) | 693 | $0.00 | $0 | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Open-market sale | 25,000 | $30.12 | $752.9K | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 2,819 | $3.18 | $9.0K | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 21,488 | $3.74 | $80.4K | Form 4 |
| 2026-03-31 | Krasney Karen | Officer (EVP, GENERAL COUNSEL) | Option exercise / conversion | 693 | $1.39 | $963 | Form 4 |
Ask the chat about CAPR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CAPRICOR THERAPEUTICS INC (CAPR).
Last updated 2026-06-25 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.